CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 159 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402,000 | +140.7% | 14,746 | +96.4% | 0.00% | – |
| Q2 2023 | $167,000 | -69.7% | 7,507 | -70.6% | 0.00% | – |
| Q1 2023 | $552,000 | +23.2% | 25,519 | +15.4% | 0.00% | – |
| Q4 2022 | $448,000 | +143.5% | 22,104 | +208.5% | 0.00% | – |
| Q3 2022 | $184,000 | -45.9% | 7,166 | -49.9% | 0.00% | – |
| Q2 2022 | $340,000 | +117.9% | 14,314 | +106.2% | 0.00% | – |
| Q1 2022 | $156,000 | -58.2% | 6,941 | -63.2% | 0.00% | – |
| Q4 2021 | $373,000 | -71.5% | 18,881 | -71.6% | 0.00% | – |
| Q3 2021 | $1,310,000 | -16.3% | 66,586 | -6.4% | 0.00% | – |
| Q2 2021 | $1,565,000 | -16.0% | 71,141 | -9.2% | 0.00% | -100.0% |
| Q1 2021 | $1,863,000 | -49.5% | 78,312 | -44.4% | 0.00% | 0.0% |
| Q4 2020 | $3,686,000 | +5.3% | 140,929 | -30.0% | 0.00% | 0.0% |
| Q3 2020 | $3,502,000 | -0.5% | 201,216 | -3.9% | 0.00% | 0.0% |
| Q2 2020 | $3,521,000 | +41.6% | 209,308 | +0.1% | 0.00% | 0.0% |
| Q1 2020 | $2,486,000 | +465.0% | 209,032 | +475.0% | 0.00% | – |
| Q4 2019 | $440,000 | -13.7% | 36,351 | +0.6% | 0.00% | – |
| Q3 2019 | $510,000 | +26.2% | 36,151 | -0.4% | 0.00% | – |
| Q2 2019 | $404,000 | +42.8% | 36,294 | +50.9% | 0.00% | – |
| Q1 2019 | $283,000 | -40.3% | 24,057 | -32.2% | 0.00% | – |
| Q4 2018 | $474,000 | -11.4% | 35,459 | -8.5% | 0.00% | – |
| Q3 2018 | $535,000 | +3243.8% | 38,753 | +3775.3% | 0.00% | – |
| Q2 2018 | $16,000 | -15.8% | 1,000 | -15.8% | 0.00% | – |
| Q1 2018 | $19,000 | -24.0% | 1,187 | -14.4% | 0.00% | – |
| Q4 2017 | $25,000 | -95.0% | 1,387 | -94.7% | 0.00% | – |
| Q3 2017 | $505,000 | +91.3% | 26,183 | +17.2% | 0.00% | – |
| Q2 2017 | $264,000 | +91.3% | 22,335 | +76.9% | 0.00% | – |
| Q1 2017 | $138,000 | -54.2% | 12,627 | -69.5% | 0.00% | – |
| Q4 2016 | $301,000 | +30000.0% | 41,465 | +27728.9% | 0.00% | – |
| Q4 2015 | $1,000 | -90.9% | 149 | -95.1% | 0.00% | – |
| Q3 2015 | $11,000 | -38.9% | 3,040 | +3.8% | 0.00% | – |
| Q2 2015 | $18,000 | +800.0% | 2,929 | +632.2% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 400 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |